Press Release: GenomOncology : Belay Diagnostics Partners with GenomOncology to Support High-Performance Liquid Biopsy Test for Central Nervous System Cancer Detection
/PRNewswire/ -- Belay Diagnostics announces its partnership with GenomOncology (GO), a precision medicine software company that provides data-driven tools and...
Read full article »
Chairman & CEO
Bradley Wertz
GenomOncology provides genome-based molecular data and decision-support solutions for cancer treatment and research centers.
Read more